Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Two Device Industry Veterans Join Boston Scientific’s Board

This article was originally published in The Gray Sheet

  • News

Executive Summary

Hologic CEO Stephen MacMillan and former Covidien exec Charles Dockendorff have been elected to Boston Scientific’s board of directors, adding significant device industry expertise to the mix. MacMillan will be the only active device industry CEO for another company on the board.

You may also be interested in...



People Briefs: Covidien CFO To Retire; Appointments At ConvaTec, Metamark, NeuroSigma, Uroplasty

Covidien Chief Financial Officer Charles Dockendorff announces retirement. ConvaTec, Metamark, NeuroSigma and Uroplasty appoint executives. More people briefs.

People Briefs: New CEO At Hologic; Departures At MDMA

Hologic appoints former Stryker CEO MacMillan president and CEO. Two staffers leave MDMA for device firms. More people briefs.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Table

View full table

Related Companies

Tags:
Latest Headlines

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

See All
UsernamePublicRestriction

Register

MT033709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By